Fil LTD Mersana Therapeutics, Inc. Transaction History

Fil LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $448,672 - $758,445	-52,415 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$15.31 - $26.52 $802,473 - $1.39 Million	52,415 New	52,415 $848,000
Q3 2020 Nov 13, 2020	SELL	$16.2 - $25.7 $5,265 - $8,352	-325 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$5.24 - $23.4 $1,703 - $7,604	325 New	325 $8,000
Q1 2019 May 13, 2019	SELL	$3.51 - $7.3 $1.25 Million - $2.59 Million	-355,055 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$14.2 - $22.68 $1.68 Million - $2.68 Million	-118,352 Reduced 25.0%	355,055 $6.34 Million
Q4 2017 Feb 12, 2018	BUY	$14.95 - $19.9 $7.08 Million - $9.42 Million	473,407	473,407 $7.78 Million

130

104M

58.5K

471K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $56.4M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.